JAK2 and diffuse large B-cell lymphoma: The combined results indicate that the IL‐6R/STAT3 signaling axis is preferentially but not exclusively active in ABC‐DLBCL, and a negative prognosticator for both subtypes; STAT3 phosphorylation correlates with activation of the upstream kinase JAK2.